1. Home
  2. NTRA vs DHI Comparison

NTRA vs DHI Comparison

Compare NTRA & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$261.99

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

HOLD

Current Price

$146.76

Market Cap

43.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
DHI
Founded
2003
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.1B
43.8B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
NTRA
DHI
Price
$261.99
$146.76
Analyst Decision
Strong Buy
Hold
Analyst Count
15
14
Target Price
$259.07
$166.08
AVG Volume (30 Days)
1.3M
2.4M
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
1.19%
EPS Growth
0.65
N/A
EPS
N/A
7.45
Revenue
$210,939,000.00
$34,250,400,000.00
Revenue This Year
$18.08
$0.05
Revenue Next Year
$19.65
$5.85
P/E Ratio
N/A
$33.28
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$131.75
52 Week High
$288.04
$183.62

Technical Indicators

Market Signals
Indicator
NTRA
DHI
Relative Strength Index (RSI) 52.98 41.87
Support Level $261.63 $134.51
Resistance Level $288.04 $150.06
Average True Range (ATR) 10.37 4.95
MACD -3.55 -1.34
Stochastic Oscillator 23.31 29.15

Price Performance

Historical Comparison
NTRA
DHI

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About DHI D.R. Horton Inc.

D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

Share on Social Networks: